Alkem Laboratories Limited has informed the Exchange about receipt of EU GMP Certificate for the Company s manufacturing facility located at Baddi, India.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories has received an EU GMP Certificate from the German Health Authority (Department of Pharmacy – Human Medicines) for its manufacturing facility located in Baddi, India. This follows an inspection conducted from November 4 to November 10, 2025, which Alkem had previously disclosed on November 10, 2025. The certificate of GMP compliance is valid for 3 years from the date of inspection. With this certification, the Baddi facility is now cleared to manufacture and supply pharmaceutical products to EU-regulated markets. The disclosure has been made under SEBI LODR Regulation 30 and will be posted on the company's website.
Positive for shareholders — this regulatory clearance strengthens Alkem's ability to serve European markets, supports its export-driven growth strategy, and removes a key compliance overhang that existed since the inspection was first flagged in November 2025.